← Alle mensen

HN

Hiroyuki Nishiyama

6 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer.

The New England journal of medicine · 18 december 2025

Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final anal...

Lancet (London, England) · 8 november 2025

Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer.

The New England journal of medicine · 14 november 2024

Rogaratinib versus chemotherapie bij FGFR-positief urotheelcarcinoom: FORT-1 fase II/III

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 januari 2023

Adjuvant atezolizumab versus observatie bij spierinvasief urotheelcarcinoom: IMvigor010 fase III

The Lancet. Oncology · 2021-04

Ramucirumab plus docetaxel versus placebo plus docetaxel bij urotheelcarcinoom na platina: RANGE fase III

Lancet (London, England) · 18 november 2017